In more than a decade of practicing fertility medicine, one of the most consistent features of every first consultation — whether the couple is young and just beginning to explore their options or has already been through failed cycles elsewhere — is the presence of misinformation.
Not ignorance. Misinformation — specific, often confidently held beliefs about IVF that are partially or entirely inaccurate, and that shape the couple's decisions, their expectations, and their willingness to pursue treatment in ways that are sometimes clinically harmful.
Some of this misinformation comes from online sources. Some from well-meaning relatives who heard something about someone's experience. Some from cultural narratives about IVF that have solidified into assumptions before evidence was ever considered. And some — it must be honestly said — from clinical encounters in which the explanation given was incomplete or poorly calibrated to what the patient actually needed to understand.
The ten myths addressed in this article are the ones I encounter most frequently in clinical practice. They are the beliefs that most commonly delay treatment, create unnecessary fear, lead to inappropriate clinical decisions, or cause couples to abandon hope when hope was actually well-founded.
Correcting them is not simply an exercise in factual accuracy. It is a clinical service — because the couple who understands what IVF actually involves is a couple who can make genuinely informed decisions about whether and how to pursue it.
Myth 1: IVF Babies Are Not Normal — They Have More Health Problems
This is perhaps the most deeply rooted and most persistently damaging myth in Indian fertility medicine. The belief that children born through IVF — commonly called test tube babies — are somehow different from naturally conceived children, more fragile, more likely to be unwell, or less "normal" in some unspecified way, prevents couples who need IVF from pursuing it.
The evidence is clear and consistent. Children born through IVF are not, as a group, significantly less healthy than naturally conceived children. The large-scale epidemiological studies that have followed IVF-conceived children for decades — including studies of adults who were the first generation of IVF babies, now in their 40s — have found no meaningful difference in overall health, intelligence, educational attainment, or quality of life compared to non-IVF-conceived peers.
There are specific, modest risks associated with IVF that deserve honest acknowledgment. Multiple pregnancy — twins or higher-order multiples — from IVF is associated with higher rates of prematurity and its consequences, but this risk is largely addressed by the modern practice of single embryo transfer. Some studies have found small increases in specific rare conditions — including certain imprinting disorders — in IVF-conceived children, but the absolute risk remains very low and is substantially lower than the risk of not treating infertility at all.
The test tube baby of popular imagination — unhealthy, abnormal, manufactured — is not what IVF produces. IVF produces babies. Healthy babies, in the large majority of cases, who grow into healthy children and healthy adults. The first IVF baby, Louise Brown, is now in her mid-forties and in good health. India's first IVF baby, born in 1978, is similarly well.
Myth 2: IVF Always Works on the First Try
The opposite of excessive pessimism, this myth represents excessive optimism — and it causes significant harm when couples enter their first IVF cycle expecting a guaranteed outcome and encounter instead what all IVF involves: uncertainty, a probability of success rather than a certainty, and the real possibility that the first cycle will not result in a pregnancy.
The live birth rate per IVF cycle in India is approximately 35 to 45 percent for women under 35 — which means the most likely single outcome of any one cycle is not pregnancy. This is not a failing of the medicine. It is the reality of human reproductive biology, in which no single attempt — natural or assisted — carries a probability of one.
Understanding this before the cycle begins — genuinely understanding it, not just nodding when it is mentioned — prepares couples for the emotional experience of the result in a way that false expectations cannot. A couple who knows, concretely, that there is a 60 percent or greater chance that the first cycle will not result in pregnancy is a couple who will be devastated but not destroyed if that outcome occurs, and who will be in a position to consider next steps with clarity rather than from a place of shock.
Myth 3: IVF Is Only for Women — Men Have Nothing to Do With It
This myth — extraordinarily persistent in a cultural context that frequently treats infertility as a female problem — has direct clinical consequences. It leads to inadequate male investigation, delayed diagnosis of male factor infertility, and the application of IVF protocols that do not address the male contribution to the couple's fertility problem.
Male factor infertility contributes to approximately half of all infertile couples. Sperm DNA fragmentation — invisible to the standard semen analysis — is a significant cause of IVF failure that affects the male partner. The investigation and treatment of male factor infertility is not a peripheral consideration in IVF — it is as central as the investigation and treatment of the female factor.
The male partner's role in IVF extends well beyond providing a semen sample on retrieval day. His sperm quality — including parameters that the standard semen analysis does not measure — directly determines embryo developmental quality and implantation probability. His lifestyle choices — smoking, alcohol, heat exposure, antioxidant status — affect the sperm that fertilize his partner's eggs in the IVF cycle. And his emotional presence — his active, informed engagement with the treatment process — affects the couple's experience and resilience through the demands of the cycle.
IVF is a couples' treatment. Both partners matter. Both partners should be thoroughly investigated. And both partners' health optimization before the cycle begins is clinically significant.
Myth 4: IVF Is Extremely Painful and the Process Is Unbearable
Fear of pain is one of the most commonly cited reasons couples delay seeking fertility treatment. The perception of IVF as involving intolerable physical suffering — drawn from dramatic accounts, exaggerated representations, or the simple unfamiliarity of a process that involves injections and a surgical procedure — prevents couples from pursuing the treatment they need.
The reality is more manageable. The daily subcutaneous injections of the stimulation phase cause mild stinging at the injection site — comparable to a standard vaccine injection. Most patients adapt within two to three days. The abdomen may become tender as follicles develop, but this is typically a heaviness or fullness rather than pain.
The egg retrieval is performed under sedation — the patient is unconscious and does not experience the procedure. Post-retrieval cramping, similar to menstrual discomfort, is common for a few hours and is managed with standard analgesics.
The embryo transfer causes minimal to no discomfort — comparable to a cervical smear, and often felt less than that.
The most demanding experience of the IVF process is emotional, not physical — the two-week wait and the anxiety of the pregnancy test. This is a genuine difficulty. But it is a different kind of difficulty from physical pain, and managing it requires emotional preparation rather than the bracing for unbearable suffering that the pain myth creates.
Myth 5: IVF Causes Early Menopause by Using Up All Your Eggs
This myth — the belief that IVF stimulation depletes the egg supply and brings forward menopause — is widespread in India and prevents many women, particularly younger women with good reserve, from pursuing IVF when it is indicated.
The truth requires understanding how ovarian stimulation works. In a natural menstrual cycle, the body recruits a cohort of small follicles — typically fifteen to thirty, depending on reserve — each month. Of these, one grows to dominance and is released at ovulation. The rest — the non-dominant follicles — undergo atresia, a natural programmed death. They are not preserved; they are simply lost, as they would be in every natural cycle.
IVF stimulation uses the same cohort of follicles that would have been recruited in that cycle regardless. The gonadotropin medications rescue follicles from atresia — preventing the natural loss of the non-dominant follicles and instead developing all of them to a mature, retrievable size. The follicles retrieved in an IVF cycle are not taken from the future reserve. They are follicles that would have been lost in that very cycle even without IVF.
IVF does not deplete the egg supply beyond what natural cycling would have produced. Each IVF stimulation cycle uses approximately the same number of follicles as one natural cycle — just develops them all to maturity rather than allowing all but one to die. The reserve — as measured by AMH — does not decline faster with IVF than with natural cycling.
Myth 6: IVF Is Only for Older Women Who Cannot Conceive Naturally
This myth operates in both directions. It causes older women to delay IVF because they assume it will not work for them — when in fact IVF is often the most efficient treatment for age-related fertility decline. And it causes younger women and couples to dismiss IVF as unnecessary or premature — when in fact specific conditions, particularly blocked tubes, severe male factor, or failed simpler treatments, make IVF the clinically appropriate first-line treatment regardless of age.
IVF has specific indications — blocked fallopian tubes, severe male factor infertility, failure of simpler treatments after appropriate clinical assessment — that apply to couples of any age. A 27-year-old woman with bilateral blocked tubes needs IVF as much as a 38-year-old with diminished reserve. Age is one determinant of which treatment is recommended, but it is far from the only one, and it does not make IVF appropriate only at older ages.
Conversely, for older women — particularly those over 38 — the association of IVF with failure is unfair. IVF success rates do decline with age, but significant proportions of women in their late thirties and early forties achieve pregnancy through IVF, particularly when the assessment is thorough and the protocol is designed around the individual patient's specific reserve and clinical picture.
Myth 7: If IVF Failed Once, It Will Never Work
The belief that a single failed IVF cycle predicts permanent failure is both clinically inaccurate and profoundly damaging. It is one of the most consequential myths in fertility medicine — because it causes couples who could achieve pregnancy through a different approach to abandon treatment entirely.
A single IVF cycle is one data point, not a verdict. The information embedded in a failed cycle — how the eggs responded to stimulation, how the embryos developed, whether implantation occurred — is clinical information that, when properly analyzed, should change how the next cycle is designed. A cycle that produced poor embryos tells something about sperm or egg quality. A cycle that produced good embryos but failed implantation tells something about the uterine environment. A cycle that produced good embryos, showed implantation, but lost the pregnancy tells something about the embryo's chromosomal status or the immunological environment.
The failed cycle is not proof that IVF cannot work. It is evidence about what needs to change — and changing the right thing, based on a thorough analysis of what the previous cycle revealed, gives the next cycle a meaningfully different probability of success.
Myth 8: IVF Medications Cause Cancer
The concern that fertility medications — particularly the gonadotropin injections used for ovarian stimulation — increase the risk of ovarian cancer or breast cancer is one that many couples raise, often having encountered it online or from concerned relatives.
The evidence does not support this concern. Multiple large-scale epidemiological studies — some following women for twenty years or more after IVF — have not found a significantly elevated rate of ovarian or breast cancer in women who have undergone IVF stimulation compared to the general population or to infertile women who did not undergo IVF.
There is a modest association between infertility itself — independent of treatment — and ovarian cancer risk, likely reflecting shared hormonal and genetic factors. But the IVF medications, used in the doses and durations typical of clinical practice, have not been demonstrated to independently elevate cancer risk in well-designed studies.
This is not a reason to dismiss the concern — any health decision should involve an honest risk-benefit assessment. But it is a reason to be accurate about what the evidence shows, and the evidence shows no significant cancer risk from IVF stimulation medications used appropriately.
Myth 9: Natural Conception Is Always Better — IVF Is Unnatural
The framing of IVF as "unnatural" — and therefore somehow inferior, problematic, or less valid as a path to parenthood — reflects a cultural narrative that privileges the means of conception over the outcome. It is a narrative that causes genuine suffering in couples for whom IVF is the only realistic path to biological parenthood.
IVF is a medical technology. It uses biological material — the couple's own eggs and sperm — to achieve what natural conception cannot, in situations where natural conception is prevented by specific medical obstacles. The pregnancy that results from IVF is a biological pregnancy, gestated in the mother's uterus, delivered in the normal way, and constituting a child in every meaningful sense identical to a naturally conceived child.
The naturalness or unnaturalness of the process by which two people become parents is, from the child's perspective, entirely irrelevant. From the parents' perspective, the medical technology that gave them a child is not a diminishment of the relationship — it is its foundation. The families formed through IVF are families. The children born through IVF are children. The love that binds them is not conditional on the method of conception.
Myth 10: IVF Is Too Expensive for Anyone Outside Big Cities
The belief that IVF is financially accessible only to urban, affluent couples — and that couples from smaller cities, towns, and rural areas must travel to metropolitan centers to access it — has historically been substantially true in North India. It is no longer entirely true.
Metro IVF Test Tube Baby Center in Ambikapur — led by Dr. Ashish Soni, North India's first fertility super specialist — brings subspecialized IVF care to the heart of Central India. The cost at Metro IVF is competitive with large-city clinics and often substantially lower, without any compromise in clinical quality, laboratory standards, or the expertise of the specialist.
For couples in Chhattisgarh, Jharkhand, Madhya Pradesh, and the surrounding region — who would previously have faced not only the cost of IVF itself but the additional cost of travel, accommodation, and time away from work for multiple visits to a distant metropolitan center — Metro IVF in Ambikapur has changed the financial equation of IVF in this region.
The myth that quality IVF is available only in cities and only at prohibitive cost is a myth that Metro IVF exists specifically to disprove.
The Common Thread — Information Changes Decisions
Every myth on this list has the same consequence: it changes what couples decide to do — and almost always in a direction that reduces their access to the treatment they need, delays it unnecessarily, or prevents them from giving it the best possible chance when they do pursue it.
Accurate information does not guarantee a successful IVF outcome. But it creates the conditions under which couples can make genuinely informed decisions — about whether to pursue treatment, which treatment to pursue, what to expect from it, and how to interpret the results they receive.
That is what this article — and every conversation in the consultation room at Metro IVF — is designed to produce.
Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist
Myths delay treatment. Facts empower decisions. Book your consultation with Dr. Ashish Soni at Metro IVF today — and get the accurate information your fertility journey deserves.